Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for NOVOLOG
- Comparison of the Pharmacokinetics (PK) and Pharmacodynamics (PD) Biosimilarity of Proposed Biosimilar Rapid-Acting Insulin Aspart (I004) and NovoLog After Single-Dose Subcutaneous Administration to Healthy Volunteers
- AT247, NovoLog® and Fiasp® Administered Via Continuous Subcutaneous Infusion in Glucose Clamp Study
- AT278 and NovoRapid® in Glucose Clamp Study
- Transition From Basal/Bolus to Once-weekly Subcutaneous Semaglutide and Basal Insulin in Patients With Type-2 Diabetes Mellitus
- Novolog vs. Fiasp Insulin in Non-critically Ill Hospitalized Patients With Type 2 Diabetes Mellitus
- Oral Anti Diabetic Agents in the Hospital
- The Efficacy and Safety of Faster Insulin Aspart (Fiasp®) Compared to Conventional Insulin Aspart (NovoLog®) as Correction Bolus
- Safety and Efficacy of Combining Intranasal Insulin & Acute Exercise
- PK/PD Study of Gan & Lee Insulin Aspart Injection vs. US & EU NovoLog®/NovoRapid® in Healthy Males
- FIasp® vs. Novolog® in Type 1 Diabetics Using 670G Medtronic Pump
- Comparison of Exposure and Activity of SAR341402 Mix 70/30 to NovoLog Mix 70/30, NovoMix 30 and SAR341402 Rapid-acting Solution in Patients With Type 1 Diabetes Mellitus
- Comparison of SAR341402 to NovoLog in Adult Patients With Type 1 Diabetes Mellitus Also Using Insulin Glargine
- Mylan Insulin Aspart Study
- IDegLira HIGH Trial
- The Insulin-Only Bionic Pancreas Bridging Study
- Evaluation of Fiasp® (Fast Acting Insulin Aspart) in 670G Hybrid Closed-Loop Therapy
- Use of NPH Versus Basal Bolus Insulin for Steroid Induced Hyperglycemia
- Safety Assessment of SAR341402 and NovoLog® Used in Continuous Subcutaneous Insulin Infusion for Type 1 Diabetes Mellitus Patients
- A Trial Comparing Insulin Degludec and Glargine U100 for Management of Hospitalized and Discharged Patients With Type 2 Diabetes
- Research Study Comparing a New Medicine "Fast-acting Insulin Aspart" to Another Already Available Medicine "NovoRapid"/"NovoLog" in People With Type 2 Diabetes
- Individualizing Automated Closed Loop Glucose Control Through Pharmacokinetic Profiling in an Insulin-Only Bionic Pancreas
- Comparison of SAR341402 to NovoLog/NovoRapid in Adult Patients With Diabetes Mellitus Also Using Insulin Glargine
- A Study to Compare Pharmacokinetics (PK) and Pharmacodynamics (PD) of SAR341402 to Insulin Aspart in Subjects With Type 1 Diabetes Mellitus
- Stepping-down Approach in Patients With Chronic Poorly-controlled Diabetes on Advanced Insulin Therapy?
- Sitagliptin in Non-Diabetic Patients Undergoing General Surgery
- A Study Comparing the Efficacy and Safety of the Morning Injection of Toujeo Versus Lantus in Patients With Type 1 Diabetes Mellitus
- Sitagliptin for Hyperglycemia in Patients With T2DM Undergoing Cardiac Surgery
- Sitagliptin in Non-Diabetic Patients Undergoing Cardiac Surgery
- Benefits of Insulin Supplementation for Correction of Hyperglycemia in Patients With Type 2 Diabetes
- Randomized Trial Comparing Sitagliptin to Placebo in Closed Loop
- CONSISTENT 1: Metabolic and Safety Outcomes of Hylenex Recombinant (Hyaluronidase Human Injection) Preadministered at CSII Infusion Site in Participants With Type 1 Diabetes Mellitus (T1DM)
- Glycemic Control Using Insulin Levemir Versus Insulin NPH for Diabetes in Pregnancy
- A Randomised Trial Evaluating Continuous Subcutaneous Infusion of Formulations of NN1218 and NovoLog® in Subjects With Type 1 Diabetes
- Study of Effectiveness of Liraglutide Added to High Dose Insulin in Type II Diabetics
- Insulin Therapy for Post-transplant Glucocorticoid Induced Hyperglycemia
- Effect of Apidra Compared to Humalog in Decreasing Post-Prandial Hyperglycemia
- Cardiac Surgery Neuroprotection Study in Elders
- Randomized, Double Blind, 2 Way Crossover Study of CSII With, Versus Without, Pretreatment With Human Hyaluronidase
- Comparison of Two Biphasic Insulin Aspart 30 Formulations (Current and New Formulation) in Healthy Volunteers
- Safety and Efficacy Study of Insulin Lispro Versus Insulin Aspart in Participants With Type 2 Diabetes on Insulin Pump Therapy
- Bioequivalence of Two NovoLog® Formulations in Subjects With Type 1 Diabetes
- Carbohydrate Consumption as a Factor in Aspart Dosing
- Randomized, Double-blind, Crossover, Pharmacokinetic (PK) and Glucodynamic (GD) Study of Continuous Subcutaneous Insulin Infusion (CSII) in Participants With Type 1 Diabetes Mellitus (T1DM)
- Use of Exenatide and Pramlintide to Decrease Post-prandial Hyperglycemia
- Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Patients With Type 2 Diabetes Mellitus
- Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Participants With Type 1 Diabetes Mellitus
- Mechanisms of Insulin Facilitation of Memory
- Prandial Insulin Dosing in Hospitalized Patients
- Effect of a Basal/Pre-Meal Insulin Strategy (Detemir/Aspart) on Insulin Secretion and Action in Type 2 Diabetes
- A Pharmacokinetic and Glucodynamic Study of Subcutaneously Administered Insulin Analogs With rHuPH20 Compared to Insulin Analogs Alone
- Use of Exenatide and Pramlintide to Decrease Post-prandial Hyperglycemia
- Aggressive Versus Conservative Blood Glucose Control in Hospitalized Type 2 Diabetic Patients Using Detemir and Aspart Insulin
- Sensor-Augmented Insulin Delivery: Insulin Plus Glucagon Versus Insulin Alone
- Efficacy of Biphasic Insulin Aspart 30 in Type 2 Diabetics Failing on OADs
- Active Comparator Study of Generex Oral-lyn™ Spray and Injected Human Insulin
- A Study to Evaluate the Effect of Nasal Insulin on Postprandial Glycemic Control in Type 2 Diabetic Patients
- Insulin Detemir Versus NPH Insulin In Hospitalized Patients With Diabetes
- Comparison of Insulins Aspart and Lispro in Insulin Pumps
- Glycemic Stability of Insulin Aspart Versus Insulin Lispro in Insulin Pump Therapy
- Insulin Glargine "All to Target" Trial
- Evaluation of an Algorithm for Intensive s.c. Insulin Therapy in Emergency Room Patients With Hyperglycaemia
- Effects of Biphasic Insulin Aspart 70/30 vs. Exenatide in Type 2 Diabetes Patients Not Reaching Blood Glucose Targets on Metformin and a Sulfonylurea.
- INITIATE Plus (INITiation of Insulin to Reach A1c TargEt) Study
- Comparison of Biphasic Insulin Aspart 70/30 With Anti-Diabetic Drugs in Subjects With Type 2 Diabetes
- Safety and Efficacy of NovoLog vs. Humalog in Insulin Pumps in Children and Adolescents
- NovoLog Observation Trial in Subjects With Type 1 and Type 2 Diabetes
- Exenatide Compared With Twice-Daily Biphasic Insulin Aspart in Patients With Type 2 Diabetes Using Sulfonylurea and Metformin
- Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
- Safety and Efficacy of Insulin Aspart vs. Regular Human Insulin in Gestational Diabetes
Clinical trials list
click for details